Menu Search
Equities

Inter Pharma PCL

IPTBF:PNK

Inter Pharma PCL

Actions
  • Price (USD)--
  • Today's Change--
  • Shares traded--
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Inter Pharma Public Company Limited is a Thailand-based biopharmaceutical company. The Company is engaged in the import, manufacture and distribution of drug, dietary supplement products for humans and animals. Its segment includes Human healthcare, Animal healthcare, and Hospital. It provides animal health care products and human health care products. It develops and delivers health products that use biotechnology for disease prevention, longevity, and anti-aging. Its human health care products include pharmaceuticals, nutraceuticals / health supplements, cosmeceuticals, functional foods and drinks and others. Its animal health care products include medicine companion animal, neutraceuticals companion animal, shampoo, vaccine and immunoglobulin, premium pet food, ear cleaner, teeth cleaner and pee pad. Its products include ProLivo, Pronac Mood, Probac 7 and others. It also offers pet foods for dogs and cats. Its subsidiaries include Inter Vetta Co., Ltd., and Modern Pharma Co., Ltd.

  • Revenue in THB (TTM)1.79bn
  • Net income in THB26.52m
  • Incorporated2019
  • Employees282.00
  • Location
    Inter Pharma PCL140/9 ITF Tower 9th FloorSilom Road, SuriyawongBANGKOK 10500ThailandTHA
  • Phone+66 26340225
  • Fax+66 26340135
  • Websitehttps://www.interpharma.co.th/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.